Search by Drug Name or NDC

    NDC 71610-0160-16 Doxazosin 8 mg/1 Details

    Doxazosin 8 mg/1

    Doxazosin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is DOXAZOSIN MESYLATE.

    Product Information

    NDC 71610-0160
    Product ID 71610-160_c783db8d-05dc-4b11-9f6a-bcb821b73cac
    Associated GPIs 36202005100340
    GCN Sequence Number 015587
    GCN Sequence Number Description doxazosin mesylate TABLET 8 MG ORAL
    HIC3 J7B
    HIC3 Description ALPHA-ADRENERGIC BLOCKING AGENTS
    GCN 33434
    HICL Sequence Number 006031
    HICL Sequence Number Description DOXAZOSIN MESYLATE
    Brand/Generic Generic
    Proprietary Name Doxazosin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Doxazosin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 8
    Active Ingredient Units mg/1
    Substance Name DOXAZOSIN MESYLATE
    Labeler Name Aphena Pharma Solutions - Tennessee, LLC
    Pharmaceutical Class Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075580
    Listing Certified Through 2024-12-31

    Package

    NDC 71610-0160-16 (71610016016)

    NDC Package Code 71610-160-16
    Billing NDC 71610016016
    Package 6000 TABLET in 1 BOTTLE (71610-160-16)
    Marketing Start Date 2018-09-20
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL f1dc70f6-4329-46da-8990-7bd6eec9d37d Details

    Revised: 12/2021